Back to Knowledge Center
Infectious Diseases ICD-10: A42.9

Actinomycosis

A chronic bacterial infection causing indurated, woody masses and sinus tracts draining 'sulfur granules,' usually in the jaw or face.

Source: WHO / CDC / NIH Evidence Guidelines
Updated: Aug 18, 2026
1,080 Views
Red Flag Warning & Emergency Situations

Emergency Management: Acute airway compromise in extensive cervicofacial disease.

Core Definition:

Actinomycosis is a rare, subacute to chronic bacterial infection characterized by contiguous spread, suppurative and granulomatous inflammation, and formation of multiple abscesses and sinus tracts that may discharge sulfur granules. It is primarily caused by Actinomyces species, which are normal flora of the oral cavity, gastrointestinal tract, and urogenital tract. The infection most commonly affects the cervicofacial region.

Detailed Overview

Actinomycosis is an endogenous infection that typically occurs following mucosal disruption, such as from dental extraction, trauma, or surgery. The bacteria, predominantly Actinomyces israelii, are anaerobic or microaerophilic Gram-positive bacilli that do not respect tissue planes during infection. They form rock-hard, indurated masses with woody fibrosis, leading to tissue destruction and fistula formation.

Epidemiology & Demographics

Actinomycosis is rare, with an estimated incidence of 1 in 300,000 per year. It is more common in males (3:1 ratio) and typically affects individuals aged 20 to 60 years. Cervicofacial disease accounts for 50-60% of cases, abdominopelvic 20%, thoracic 15%.

Etiological Mechanism

Caused primarily by Actinomyces israelii, with other species like A. naeslundii, A. viscosus frequently involved. Infections are usually polymicrobial, involving companion bacteria such as Aggregatibacter actinomycetemcomitans.

Primary Causes

Mucosal barrier disruption allowing normal flora to invade deep tissues, commonly resulting from poor dental hygiene, dental procedures, abdominal surgery, or prolonged intrauterine device (IUD) use.

Following mucosal injury, Actinomyces species invade deep tissues in a low oxygen environment. They form complex polymicrobial clusters that resist phagocytosis. The infection spreads slowly, ignoring fascial planes, triggering a chronic granulomatous and suppurative inflammatory response. This leads to intense local fibrosis ('woody induration') and central necrosis, eventually breaking through the skin or mucosa to form sinus tracts that extrude yellowish clumps of bacteria and calcium phosphate known as 'sulfur granules.'

Diagnostic Criteria & Guidelines

Definitive diagnosis requires isolation of Actinomyces species from a sterile site or typical histopathological findings of 'sulfur granules' (basophilic masses with eosinophilic clubs on H&E stain) in the setting of compatible clinical signs.

First-Line Treatment:

Penicillin G 18-24 million units IV daily for 2-6 weeks, followed by Amoxicillin 500 mg PO TID for 6-12 months.

Second-Line & Adjunctive Therapy

Doxycycline 100 mg PO BID or Ceftriaxone 2 g IV daily, followed by Clindamycin 300 mg PO QID for 6-12 months.

Surgical & Procedural Management

Surgical resection and drainage if abscesses are large or for relief of obstruction.

Patient Counseling & Advice

Inform the patient that treatment is very long (up to a year) to ensure total eradication and prevent relapse.

Follow-Up & Monitoring Schedule

Monthly clinical review initially, followed by regular imaging to ensure the mass is resolving.

Preventive Strategies

Optimal oral hygiene, timely treatment of dental caries, limit IUD placement duration to under 5 years.

Cure rates are over 90% with prolonged antibiotic therapy, although residual anatomical deformity can remain.

Authoritative Sources & Evidence References
World Health Organization (WHO) & CDC Guidelines: Information compiled from current international clinical practice guidelines.

System Notice

Confirm Action